Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates.
May 18, 2017 | Antiviral Research
Eugenia Z Ong, Yadunanda Budigi, Hwee Cheng Tan, Luke N Robinson, Kirk J Rowley, Alexander Winnett, Sven Hobbie, Zachary Shriver, Gregory J Babcock, Eng Eong Ooi